We're building on our deep expertise and legacy in immunology research to explore new disease areas, create a more patient-centric discovery and development process and offer solutions for more diverse patient populations.
We leverage our deep understanding of human biology and cutting-edge research technologies to find new ways to improve the lives of people with cancer. Our scientific discoveries have made a big impact in the treatment of blood cancer, and now we're expanding our knowledge to investigate solid tumors.
Our scientists are relentless in their pursuit of raising the standards of care for neurological diseases and disorders. We are exploring innovative, disease-modifying solutions to address some of the most prevalent and serious disorders, from Parkinson's, Alzheimer's and broader movement disorders to schizophrenia, migraine and stroke.
Our innovative portfolio and pipeline of new discoveries seek to maintain vision and prevent blindness. We are focused on improving the standards of care across multiple disease areas from the front to the back of the eye, from glaucoma to chronic retinal diseases.
We create products and technologies that advance aesthetic medicine. Our aesthetics R&D team seeks to discover and accelerate comprehensive, evidence-based solutions focused on novel indications, improved delivery technologies and enhanced patient outcomes.
Beyond our core areas, our research is also focused on infectious diseases — like Hepatitis C, HIV and COVID-19 — pulmonology, endocrinology, diseases of the gastrointestinal tract and therapeutic neurotoxins. In these areas, a diverse set of scientific expertise is united by one vision — we believe impactful new discoveries for some of these patients are achievable.